FORMULA Act of 2026

Protection of Infant Health: The Secretary is directed to establish maximum levels for contaminants by considering the cumulative health impacts of low-level exposure on infant neurodevelopment (Section 2(b)(2)(3)(A)).

Enhanced Safety Standards: The bill requires the Secretary to ensure contaminant levels are as close to the maximum contaminant level goal as possible using the best available technology and treatment techniques (Section 2(b)(2)(2)).

Increased Transparency: The Secretary must include a list of manufacturers found in violation of contaminant levels and the specific concentrations of contaminants detected during routine surveillance in an annual report to Congress (Section 2(b)(2)(6)).

Accountability through Testing: Manufacturers will be required to conduct testing to ensure they are complying with the established maximum permissible contaminant levels (Section 2(b)(2)(4)(A)).

Financial Burden on Manufacturers: In prescribing regulations for contaminant levels, the Secretary is instructed to take cost into consideration (Section 2(b)(2)(2)).

Administrative Requirements for Manufacturers: Manufacturers are required to conduct testing, maintain records for at least 2 years after the shelf life of the formula expires, and make those records available to the Secretary upon request (Section 2(b)(2)(4)).